Torisel Kit
Product Images NDC 0008-1179

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Torisel (NDC 0008-1179). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Torisel 01)

Chemical structure diagram of temsirolimus, the active ingredient in Torisel. The diagram illustrates the molecular composition and connectivity of temsirolimus' atoms and functional groups.*

FDA Label Image

Figure 1 (Torisel 02)

A survival distribution function graph comparing Torisel 25 mg and Interferon over months to death from randomization. The x-axis shows months to death, and the y-axis displays survival probability, with Torisel represented by a solid line and Interferon by a dashed line.*

FDA Label Image

Logo (Torisel 03)

FDA Label Image

Principal Display Panel (25 mg/mL Vial Label)

Label for Torisel (temsirolimus) injection 25 mg/mL kit by Wyeth Pharmaceuticals LLC, a Pfizer subsidiary. The label indicates the vial contains 0.2 mL overfill, must be diluted to 10 mg/mL after initial dilution, single use, and requires refrigeration. Instructions detail dilution steps for IV infusion only. The label also carries a cytotoxic warning and handling caution.*

FDA Label Image

Principal Display Panel (2.2 mL Vial Label)

Label for the diluent component of Torisel (temsirolimus) injection kit, indicating 2.2 mL volume. The label states it is not for direct administration, only for dilution of the Torisel injection vial. It includes handling instructions noting cytotoxic caution and refrigeration storage. The label references Wyeth Pharmaceuticals LLC, a Pfizer subsidiary, and states the product is made in Italy.*

FDA Label Image

Principal Display Panel (Kit Carton)

Packaging label for Torisel Kit (temsirolimus) injection, 25 mg/mL, a concentrated prescription drug by Wyeth Pharmaceuticals LLC, a Pfizer subsidiary. The label indicates each vial contains 25 mg/mL temsirolimus with 0.2 mL overfill. The kit includes one injection vial and one diluent vial. It requires two dilutions before intravenous administration. The label provides storage instructions, caution for cytotoxic handling, and dilution information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.